India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis
Manju Rahi,Rini Chaturvedi,Payal Das,Amit Sharma
DOI: https://doi.org/10.1371/journal.ppat.1009492
IF: 7.464
2021-05-20
PLoS Pathogens
Abstract:Disease-specific programmes (also called vertical, stand-alone, categorical, or free-standing) are directed, supervised and executed via single vehicle using dedicated health workers. In contrast, integrated programmes (also known as horizontal) aim to tackle the overall health problems on a wider front and on a longer-term basis through the creation of permanent multifunctional healthcare delivery institutions [<a class="ref-tip" href="#ppat.1009492.ref001">1</a>]. Several disease control programmes like the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFTAM), Roll Back Malaria (RBM), Global Polio Eradication Initiative (GPEI) and Expanded Programme of Immunization (EPI) are vertical programmes focused on malaria, polio and other preventable diseases respectively [<a class="ref-tip" href="#ppat.1009492.ref001">1</a>]. GFTAM and other organizations have been referred to as agencies with their parallel systems of reporting, monitoring and so on. However, there are inherent differences among these agencies. Global Fund is an international organization which in partnership with national governments (including India), civil society, technical agencies, private sector and others invests significantly in scaling up preventive and management tools of TB, malaria and AIDS. Whereas other organizations like CARE India and KalaCORE India have joined hands with the government to support implementation of certain components of kala azar research and elimination programme in some endemic states of India. Vertical programmes for diseases like malaria, tuberculosis, leprosy, filaria, trachoma and cholera have been existent in India since long [<a class="ref-tip" href="#ppat.1009492.ref002">2</a>]. However, India still suffers from a significant burden of 3 parasitic vector-borne diseases, namely malaria, visceral leishmaniasis and lymphatic filariasis. Malaria is prevalent in a total of 747 districts* with approximately 698 million population at risk [<a class="ref-tip" href="#ppat.1009492.ref003">3</a>]. Visceral leishmaniasis, also known as kala azar (black fever), is endemic in 54 districts of Bihar, Jharkhand, Uttar Pradesh and West Bengal putting 130 million population at risk [<a class="ref-tip" href="#ppat.1009492.ref004">4</a>]. Lymphatic filariasis is prevalent in 256 districts and affects >23 million people with nearly 650 million people at risk of acquiring the infection in India [<a class="ref-tip" href="#ppat.1009492.ref005">5</a>]. Currently, malaria, visceral leishmaniasis and lymphatic filariasis are targeted for elimination (visceral leishmaniasis and lymphatic filariasis by 2021 and malaria by 2030) [<a class="ref-tip" href="#ppat.1009492.ref006">6</a>]. Elimination programmes pertaining to these diseases are important in the health system of India and consume substantial resources.The National Vector Borne Disease Control Programme (NVBDCP) is a focal agency of the Government of India responsible for control of 6 vector-borne diseases, i.e., malaria, visceral leishmaniasis, lymphatic filariasis, dengue, chikungunya and Japanese encephalitis. NVBDCP is a vertical programme due to separate budgets, healthcare cadres, supply chains, health information systems, monitoring, and evaluation frameworks but partially embedded in the existing mainstream healthcare system of the country at the grassroot level, especially after the advent of National Rural Health Mission (NRHM).The verticality of the 3 programmes within NVBDCP is evident in terms of staff, infrastructure and operations. Despite some attempts at integration at district level, State Programme Officers (SPOs) are different for each disease, and separate infrastructures like Filaria units still exist in some states. Vector control activities like indoor residual spray (IRS) (common for malaria and visceral leishmaniasis) and the use of larvicides (common for lymphatic filariasis and malaria) are done in an independent and disconnected fashion. The grassroots-level workers and Primary Health Centre (PHC) staff are the same for surveillance of all three, but the training programmes are segregated for each disease which does now allow practice of joint surveillance. Finally, the key aspect of surveillance in terms of data (reporting formats and health information management systems) are different and not shared. NVBDCP provides antimalarial drugs, insecticides and larvicides to the states. Operational costs of the implementation of the programme are borne by states. The implementation of the national programme is thus the responsibility of states. Similarly, for kala azar, the central government provides drugs, insecticides and technical support and the states bear implementation costs. Lymphatic filariasis programme is a centrally assisted programme including procurements of drugs for MDA and other operations.Despite the above verticality, the above programmes utilize the same network of heal <p>-Abstract Truncated-</p>
microbiology,virology,parasitology